Praxis Biotech

Praxis Biotech is a US-based company focused on the development of innovative small molecule drugs to treat patients with serious diseases such as cancer and neurological disorders. Praxis Biotech blends a unique business model with an expert team in bringing promising medical technologies from the research laboratory to the patient’s bedside. Praxis was founded by a group of experienced professionals with a long track record of working as a team in the pharmaceutical and biotechnology industries. Merken Biotech, a Praxis’ subsidiary, is a Chile-based laboratory working in preclinical discovery research and development.